Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial. [electronic resource]
Producer: 20001026Description: 534-7 p. digitalISSN:- 0277-3732
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Dipyridamole -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Mitomycin -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Survival Analysis
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.